dilluns, 9 de març del 2015

FDA approves Kaneka's Lixelle dialysis device




Kaneka wins a humanitarian device exemption from the FDA for its new Lixelle device to treat dialysis-related buildup of amyloid protein.





FDA approves Kaneka's Lixelle anti-amyloid dialysis device

The FDA last week said it approved a 1st-of-its-kind device designed to treat patients with dialysis-related buildup of amyloid protein in the body made by Japan's Kaneka (TYO:4118).


Food & Drug Administration (FDA), Kaneka

News Well, Humanitarian Device Exemption (HDE), Dialysis, Regulatory/Compliance

read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1AYciI1
a

Cap comentari:

Publica un comentari a l'entrada